Medacta Group SA (MEDGF)
- Previous Close
0.00 - Open
83.91 - Bid 125.06 x 21500
- Ask 138.24 x 21500
- Day's Range
83.91 - 83.91 - 52 Week Range
83.91 - 83.91 - Volume
63 - Avg. Volume
0 - Market Cap (intraday)
2.171B - Beta (5Y Monthly) 1.14
- PE Ratio (TTM)
33.30 - EPS (TTM)
2.52 - Earnings Date Sep 25, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date May 10, 2024
- 1y Target Est
--
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine procedures. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
www.medacta.comRecent News: MEDGF
View MorePerformance Overview: MEDGF
Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MEDGF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MEDGF
View MoreValuation Measures
Market Cap
2.63B
Enterprise Value
2.66B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
10.33%
Return on Assets (ttm)
7.11%
Return on Equity (ttm)
17.52%
Revenue (ttm)
544.29M
Net Income Avi to Common (ttm)
56.21M
Diluted EPS (ttm)
2.52
Balance Sheet and Cash Flow
Total Cash (mrq)
16.41M
Total Debt/Equity (mrq)
67.08%
Levered Free Cash Flow (ttm)
-30M